COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02187367
Brief Title: Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients (EGF)

First Submitted : July 7, 2014
First Submitted that Met QC Criteria : July 9, 2014
First Posted : July 11, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 9, 2019
Last Update Posted : September 10, 2019